PhRMA response to Washington Post and 60 Minutes stories
By Robert Zirkelbach | October 16, 2017
The opioid epidemic confronting America is a growing public health crisis from which none of us are immune. Its impact is felt by families across the country, in small towns and large cities,...
Read More
VIDEO: PhRMA CEO discusses industry response to opioid crisis on Mornings with Maria
By Holly Campbell | October 12, 2017
PhRMA president and CEO Stephen J. Ubl joined Fox Business’ Maria Bartiromo on “Mornings with Maria” today to discuss bold steps the biopharmaceutical industry has taken in the last few months as...
Read More
Protect your health: Important disaster preparedness tips for Harvey and Irma
By Guest Contributor | September 6, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
PhRMA Supports President’s Commission’s Holistic Approach on Opioid Crisis
By Anne McDonald Pritchett, PhD | August 2, 2017
Just about every day, I read a news story about the opioid crisis or talk to someone who has been personally impacted by addiction. According to the CDC, opioids, including prescription opioids...
Read More
Opportunities to build upon enhanced competition for medicines in the marketplace
By David Korn | July 27, 2017
Last week, I presented at the U.S Food and Drug Administration’s (FDA) public meeting on the Hatch-Waxman Amendments to discuss the balance between encouraging innovation in biopharmaceutical...
Read More
A critical opportunity to prevent prescription drug abuse
By Anne McDonald Pritchett, PhD | June 2, 2017
U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb recently cited addressing the opioid crisis as his highest priority. As someone who has spent the bulk of my career focused on...
Read More
Former law enforcement officials raise concerns with drug importation proposals
By Nicole Longo | May 11, 2017
Time and again, proponents of drug importation schemes overlook the major impact such proposals would have on our law enforcement officers – the men and women who spend their lives protecting...
Read More
Resources for understanding the dangers of drug importation
By Nicole Longo | March 28, 2017
Recent proposals to allow drug importation from other countries are dangerous for patients and the U.S. drug supply chain. To better understand how these importation schemes could negatively...
Read More
How drug importation schemes could increase U.S. law enforcement burdens
By Allyson Funk | March 16, 2017
In recent weeks, we’ve explored some of the dangers of importation for patients and how medicines purchased online can be fake. But what would importation schemes mean for U.S. law enforcement?
Read More
Case Study: How one online pharmacy knowingly endangered U.S. consumers
By Nicole Longo | March 2, 2017
We recently looked at what actually happens when a patient orders a medicine through an online Canadian pharmacy and how the product delivered may not be what the patient ordered. Today, we’re...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
